Ranbaxy Q1 net profit trebles on strong US sales
Facebook Twitter google+ RSS Feed

Ranbaxy Q1 net profit trebles on strong US sales

By SiliconIndia   |   Wednesday, 30 April 2003, 07:00 Hrs
Printer Print Email Email
MUMBAI: Ranbaxy Laboratories said on Tuesday its first-quarter net profit nearly tripled on booming exports of generic drugs to the United States.

Ranbaxy said January-March net profit was Rs 2.8 billion ($59.12 million), compared with a profit of Rs 949 million a year ago, whipping estimates. Sales rose 90 per cent to Rs 10.5 billion.

Ranbaxy said global sales rose 54 per cent to $233 million while global net profit rose 77 per cent to Rs 1.73 billion.

Ranbaxy and other Indian drug companies such as Dr Reddy's Laboratories and Cipla Ltd have been riding high on copycat versions of drugs going off patent.

Dr Reddy's by contrast is expected to report lower quarterly results as it lacked new blockbuster drugs in the past quarters.


Experts on SiliconIndia
Santhosh  K
Sr. Soft. Engg.
Oracle India
Nehal Vyas
Sr. Team Lead
Cyberoam Tech.
Rani Malli
Sr. Director
Philips
Sr. Executive
ISB
Vijay Balkrishna Konduskar
Business Consultant
Imans Web Tech
Dr L P  Sharma
Technical Director
NIC
Reena Khanna
Founder
Solitaireworld
Dellas  Asse
sys-network admin
Computer Station
Write your comment now
Submit Reset
SPOTLIGHT